×
About 1,405 results

ALLMedicine™ Achondroplasia Center

Research & Reviews  687 results

Childhood prevalence of achondroplasia in New South Wales and the Australian Capital Te...
https://doi.org/10.1002/ajmg.a.62142
American Journal of Medical Genetics. Part A; Tofts L, Armstrong J et. al.

Feb 27th, 2021 - The aim of this study was to estimate the childhood prevalence of achondroplasia, trends over time in birth prevalence, and age at diagnosis in Australia. Children born between 1990 and 2019 with a clinical and radiological and/or molecular diagno...

Predictors of cervical myelopathy and hydrocephalus in young children with achondroplasia.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881633
Orphanet Journal of Rare Diseases; Shim Y, Ko JM et. al.

Feb 13th, 2021 - Cervical myelopathy and hydrocephalus occasionally occur in young children with achondroplasia. However, these conditions are not evaluated in a timely manner in many cases. The current study presents significant predictors for cervical myelopathy...

Pain Phenotypes in Rare Musculoskeletal and Neuromuscular Diseases.
https://doi.org/10.1016/j.neubiorev.2021.02.009
Neuroscience and Biobehavioral Reviews; Tucker-Bartley A, Lemme J et. al.

Feb 13th, 2021 - For patients diagnosed with a rare musculoskeletal or neuromuscular disease, pain may transition from acute to chronic; the latter yielding additional challenges for both patients and care providers. We assessed the present understanding of pain a...

Apneic Seizures in a Child with Achondroplasia.
https://doi.org/10.1055/s-0041-1722879
Neuropediatrics Calame DG, Herman I et. al.

Feb 12th, 2021 - Apneic Seizures in a Child with Achondroplasia.|2021|Calame DG,Herman I,Bartlett B,Agurs L,Tran BH,|

Lifetime Impact of Achondroplasia: Current Evidence and Perspectives on the Natural His...
https://doi.org/10.1016/j.bone.2021.115872
Bone Hoover-Fong J, Cheung MS et. al.

Feb 5th, 2021 - Achondroplasia, the most common form of disproportionate short stature, is caused by a variant in the fibroblast growth factor receptor 3 (FGFR3) gene. Advances in drug treatment for achondroplasia have underscored the need to better understand th...

see more →

Clinicaltrials.gov  705 results

Childhood prevalence of achondroplasia in New South Wales and the Australian Capital Te...
https://doi.org/10.1002/ajmg.a.62142
American Journal of Medical Genetics. Part A; Tofts L, Armstrong J et. al.

Feb 27th, 2021 - The aim of this study was to estimate the childhood prevalence of achondroplasia, trends over time in birth prevalence, and age at diagnosis in Australia. Children born between 1990 and 2019 with a clinical and radiological and/or molecular diagno...

Predictors of cervical myelopathy and hydrocephalus in young children with achondroplasia.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7881633
Orphanet Journal of Rare Diseases; Shim Y, Ko JM et. al.

Feb 13th, 2021 - Cervical myelopathy and hydrocephalus occasionally occur in young children with achondroplasia. However, these conditions are not evaluated in a timely manner in many cases. The current study presents significant predictors for cervical myelopathy...

Pain Phenotypes in Rare Musculoskeletal and Neuromuscular Diseases.
https://doi.org/10.1016/j.neubiorev.2021.02.009
Neuroscience and Biobehavioral Reviews; Tucker-Bartley A, Lemme J et. al.

Feb 13th, 2021 - For patients diagnosed with a rare musculoskeletal or neuromuscular disease, pain may transition from acute to chronic; the latter yielding additional challenges for both patients and care providers. We assessed the present understanding of pain a...

Apneic Seizures in a Child with Achondroplasia.
https://doi.org/10.1055/s-0041-1722879
Neuropediatrics Calame DG, Herman I et. al.

Feb 12th, 2021 - Apneic Seizures in a Child with Achondroplasia.|2021|Calame DG,Herman I,Bartlett B,Agurs L,Tran BH,|

Lifetime Impact of Achondroplasia: Current Evidence and Perspectives on the Natural His...
https://doi.org/10.1016/j.bone.2021.115872
Bone Hoover-Fong J, Cheung MS et. al.

Feb 5th, 2021 - Achondroplasia, the most common form of disproportionate short stature, is caused by a variant in the fibroblast growth factor receptor 3 (FGFR3) gene. Advances in drug treatment for achondroplasia have underscored the need to better understand th...

see more →

News  11 results

Vosoritide Ups Height in Achondroplasia in Year-Long Phase 3 Study
https://www.staging.medscape.com/viewarticle/939744

Oct 25th, 2020 - A year of daily subcutaneous vosoritide was associated with a 0.6-inch (1.5-cm) greater increase in height than placebo in children with achondroplasia, the most common form of human dwarfism. There was no difference in the incidence of side effec...

Vosoritide Ups Height in Achondroplasia in Year-Long Phase 3 Study
https://www.medscape.com/viewarticle/939744

Oct 25th, 2020 - A year of daily subcutaneous vosoritide was associated with a 0.6-inch (1.5-cm) greater increase in height than placebo in children with achondroplasia, the most common form of human dwarfism. There was no difference in the incidence of side effec...

Health Supervision Guidance for Achondroplasia Patients Updated
https://www.medscape.com/viewarticle/931243

May 28th, 2020 - (Reuters Health) - New clinical guidance from the American Academy of Pediatrics (AAP) on health supervision across the lifespan of people with achondroplasia focuses on recent advances in technology that can help diagnose and manage patients with...

Vosoritide Boosts Growth in Kids With Achondroplasia
https://www.medpagetoday.com/pediatrics/growthdisorders/80559

Jun 18th, 2019 - Children with achondroplasia, the genetic bone growth disorder that causes disproportionate dwarfism, saw sustained increases in annualized growth velocity with an investigational C-type natriuretic peptide analogue called vosoritide, researchers ...

Novel Agent Shows Promise as First Possible Therapy for Achondroplasia
https://www.staging.medscape.com/viewarticle/914534

Jun 17th, 2019 - The results are preliminary, but a novel investigative agent has shown promise in a small trial in children for the treatment of achondroplasia, the most common form of human dwarfism. A phase 2 proof of concept study found that treatment with vos...

see more →

Patient Education  2 results see all →